These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1212 related items for PubMed ID: 17950011

  • 1. Add-on levetiracetam in children and adolescents with refractory epilepsy: results of an open-label multi-centre study.
    Callenbach PM, Arts WF, ten Houten R, Augustijn P, Gunning WB, Peeters EA, Weber AM, Stroink H, Geerts Y, Geerts AT, Brouwer OF.
    Eur J Paediatr Neurol; 2008 Jul; 12(4):321-7. PubMed ID: 17950011
    [Abstract] [Full Text] [Related]

  • 2. Efficacy and safety of levetiracetam 1000-3000 mg/day in patients with refractory partial-onset seizures: a multicenter, open-label single-arm study.
    Beran RG, Berkovic SF, Black AB, Danta G, Hiersemenzel R, Schapel GJ, Vajda FJ.
    Epilepsy Res; 2005 Jan; 63(1):1-9. PubMed ID: 15716083
    [Abstract] [Full Text] [Related]

  • 3. Efficacy and tolerability of levetiracetam in children younger than 4 years: a retrospective review.
    Perry MS, Benatar M.
    Epilepsia; 2007 Jun; 48(6):1123-7. PubMed ID: 17430408
    [Abstract] [Full Text] [Related]

  • 4. Adjunctive levetiracetam in infants and young children with refractory partial-onset seizures.
    Piña-Garza JE, Nordli DR, Rating D, Yang H, Schiemann-Delgado J, Duncan B, Levetiracetam N01009 Study Group.
    Epilepsia; 2009 May; 50(5):1141-9. PubMed ID: 19243423
    [Abstract] [Full Text] [Related]

  • 5. Levetiracetam monotherapy in children with epilepsy.
    Khurana DS, Kothare SV, Valencia I, Melvin JJ, Legido A.
    Pediatr Neurol; 2007 Apr; 36(4):227-30. PubMed ID: 17437904
    [Abstract] [Full Text] [Related]

  • 6. Open-label, long-term safety study of zonisamide administered to children and adolescents with epilepsy.
    Shinnar S, Pellock JM, Conry JA.
    Eur J Paediatr Neurol; 2009 Jan; 13(1):3-9. PubMed ID: 18343174
    [Abstract] [Full Text] [Related]

  • 7. The SKATE study: an open-label community-based study of levetiracetam as add-on therapy for adults with uncontrolled partial epilepsy.
    Steinhoff BJ, Somerville ER, Van Paesschen W, Ryvlin P, Schelstraete I.
    Epilepsy Res; 2007 Aug; 76(1):6-14. PubMed ID: 17681453
    [Abstract] [Full Text] [Related]

  • 8. Efficacy of levetiracetam in children with refractory epilepsy as an add-on trial.
    Tonekaboni SH, Ghazavi M, Karimzadeh P, Mahvelati F, Ghofrani M.
    Epilepsy Res; 2010 Aug; 90(3):273-7. PubMed ID: 20619606
    [Abstract] [Full Text] [Related]

  • 9. Adjunctive levetiracetam in children, adolescents, and adults with primary generalized seizures: open-label, noncomparative, multicenter, long-term follow-up study.
    Delanty N, Jones J, Tonner F.
    Epilepsia; 2012 Jan; 53(1):111-9. PubMed ID: 22050371
    [Abstract] [Full Text] [Related]

  • 10. Levetiracetam in a broad population of patients with refractory epilepsy: interim results of the international SKATE trial.
    Genton P, Sadzot B, Fejerman N, Peltola J, Despland PA, Steinhoff B, Rektor I, Wroe S, Maubrey MC, Vandervelden C, van Hammée G, Schlit AF, van Paesschen W.
    Acta Neurol Scand; 2006 Jun; 113(6):387-94. PubMed ID: 16674605
    [Abstract] [Full Text] [Related]

  • 11. Levetiracetam in clinical practice: long-term experience in patients with refractory epilepsy referred to a tertiary epilepsy center.
    Bootsma HP, Ricker L, Diepman L, Gehring J, Hulsman J, Lambrechts D, Leenen L, Majoie M, Schellekens A, de Krom M, Aldenkamp AP.
    Epilepsy Behav; 2007 Mar; 10(2):296-303. PubMed ID: 17317325
    [Abstract] [Full Text] [Related]

  • 12. Efficacy of levetiracetam: a review of three pivotal clinical trials.
    Privitera M.
    Epilepsia; 2001 Mar; 42 Suppl 4():31-5. PubMed ID: 11564123
    [Abstract] [Full Text] [Related]

  • 13. Levetiracetam during 1-year follow-up in children, adolescents, and young adults with refractory epilepsy.
    Coppola G, Mangano S, Tortorella G, Pelliccia A, Fels A, Romano A, Nardello R, Habetswallner F, Licciardi F, Operto FF, Pascotto A.
    Epilepsy Res; 2004 Mar; 59(1):35-42. PubMed ID: 15135165
    [Abstract] [Full Text] [Related]

  • 14. Once-daily extended-release levetiracetam as adjunctive treatment of partial-onset seizures in patients with epilepsy: a double-blind, randomized, placebo-controlled trial.
    Peltola J, Coetzee C, Jiménez F, Litovchenko T, Ramaratnam S, Zaslavaskiy L, Lu ZS, Sykes DM, Levetiracetam XR N01235 Study Group.
    Epilepsia; 2009 Mar; 50(3):406-14. PubMed ID: 19317886
    [Abstract] [Full Text] [Related]

  • 15. Use of levetiracetam in treating epilepsy associated with other medical conditions.
    Di Bonaventura C, Mari F, Fattouch J, Egeo G, Vaudano AE, Manfredi M, Prencipe M, Giallonardo AT.
    Acta Neurol Scand; 2006 Feb; 113(2):82-6. PubMed ID: 16411967
    [Abstract] [Full Text] [Related]

  • 16. Efficacy and safety of adjunctive levetiracetam therapy in pediatric intractable epilepsy.
    Lee YJ, Kang HC, Kim HD, Lee JS.
    Pediatr Neurol; 2010 Feb; 42(2):86-92. PubMed ID: 20117743
    [Abstract] [Full Text] [Related]

  • 17. Prospective assessment of levetiracetam pharmacokinetics during dose escalation in 4- to 12-year-old children with partial-onset seizures on concomitant carbamazepine or valproate.
    Fountain NB, Conry JA, Rodríguez-Leyva I, Gutierrez-Moctezuma J, Salas E, Coupez R, Stockis A, Lu ZS.
    Epilepsy Res; 2007 Apr; 74(1):60-9. PubMed ID: 17270398
    [Abstract] [Full Text] [Related]

  • 18. Multicenter double-blind, randomized, placebo-controlled trial of levetiracetam as add-on therapy in Chinese patients with refractory partial-onset seizures.
    Wu XY, Hong Z, Wu X, Wu LW, Wang XF, Zhou D, Zhao ZX, Lv CZ.
    Epilepsia; 2009 Mar; 50(3):398-405. PubMed ID: 18657175
    [Abstract] [Full Text] [Related]

  • 19. Efficacy and safety of levetiracetam as an add-on therapy in children aged less than 4 years with refractory epilepsy.
    Li S, Cao J, Xiao N, Cai F.
    J Child Neurol; 2010 May; 25(5):609-13. PubMed ID: 19779208
    [Abstract] [Full Text] [Related]

  • 20. Neurocognitive effects of adjunctive levetiracetam in children with partial-onset seizures: a randomized, double-blind, placebo-controlled, noninferiority trial.
    Levisohn PM, Mintz M, Hunter SJ, Yang H, Jones J, N01103 Levetiracetam Study Group.
    Epilepsia; 2009 Nov; 50(11):2377-89. PubMed ID: 19702752
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 61.